Cardiology

Drug sharply lowers cholesterol in animal tests

An Arizona drug company will patent a small peptide—developed through research at the University of Alabama at Birmingham—that shows significant ability to lower blood cholesterol in animal models. Capstone Therapeutics ...

Cardiology

Atorvastatin/Ezetimibe beats atorvastatin after PCI

(HealthDay)—For Japanese patients who have undergone percutaneous coronary intervention (PCI), atorvastatin plus ezetimibe is associated with improved outcomes versus atorvastatin alone, according to a study published in ...

Cardiology

Researchers find two biomarkers linked to severe heart disease

Insulin resistance affects tens of millions of Americans and is a big risk factor for heart disease. Yet, some people with the condition never develop heart disease, while some experience moderate coronary blockages. Others, ...

Immunology

Transmural control of plaque formation

In atherosclerosis, fatty "plaques" form in the inner layer of arteries. As an LMU team now shows, specialized lymphoid organs found on the outer arterial wall adjacent to plaques help to restrain the inflammation that boosts ...

Cardiology

How to turn the bad guys good in hardened arteries

Hardening of the arteries, or atherosclerosis, is one of the most common cardiovascular diseases and is a common feature of ageing but it is not good news. When complex, calcified fatty plaques accumulate and develop up on ...

page 11 from 30